Solventum Corporation / "R&D" | Tables in SEC filings

SOLV Solventum Corporation

28 Feb 25

Annual report

4:56pm

During the fourth quarter of 2024, Solventum entered into a finance lease arrangement through April 2046 for the future location of the Company's principal office in Eagan, Minnesota. The new location will include office, R&D and manufacturing space and the finance lease is expected to commence during the second quarter of 2026, at which time the Company will discontinue certain real estate license agreements with 3M.

(Millions)	2024		2023		2022
Operating lease cost		$		75	$	28	$	32

Year ended December 31,	(Percent of total net sales)		2024		2023			2022		2024 vs 2023			2023 vs 2022
Selling, general and administrative (SG&A)		33.7		%	27.4			%	27.5		%	6.3			%	(0.1)	%
Research and development (R&D)		9.4		9.2	9.4	0.2	(0.2)	Operating Income	12.6		20.6	20.8	(8.0)	(0.2)

Three months ended September 30,	Nine months ended September 30,
(Percent of total net sales)		2024	2023			Change			2024		2023			Change
Selling, general and administrative (SG&A)		33.7	%	25.3			%	8.4		%	32.3			%	27.3	%	5.0	%
Research and development (R&D)		9.1	8.7	0.4	9.3	9.2	0.1	Operating Income	13.2		24.3	(11.1)	14.6	20.9	(6.3)

Three months ended June 30,	Six months ended June 30,
(Percent of total net sales)		2024	2023			Change			2024		2023			Change
Selling, general and administrative (SG&A)		33.7	%	27.9			%	5.8		%	31.7			%	28.3	%	3.4	%
Research and development (R&D)		9.2	9.3	(0.1)	9.4	9.5	(0.1)	Operating Income	11.7		20.1	(8.4)	15.3	19.1	(3.8)

Table search / Solventum Corporation / "R&D"

5 results

Top filers

Top filing types

Recent filing years